Cargando…
Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias
Autoimmune hemolytic anemia (AIHA) and pure red cell aplasia (PRCA) are common complications of CLL. The optimal treatment of steroid refractory AIHA/PRCA is not well established. We conducted a multicenter study of ibrutinib and rituximab in patients with relapsed/refractory to steroids AIHA/PRCA a...
Autores principales: | Nikitin, Eugene, Kislova, Maria, Morozov, Dmitry, Belyakova, Vera, Suvorova, Anna, Sveshnikova, Julia, Vyscub, Galina, Matveeva, Irina, Shirokova, Maria, Shipaeva, Anna, Klitochenko, Tatyana, Makarovskaya, Polina, Dmitrieva, Elena, Biderman, Bella, Sudarikov, Andrei, Obukhova, Tatyana, Samoilova, Olga, Kaplanov, Kamil, Konstantinova, Tatyana, Mayorova, Olga, Poddubnaya, Irina, Ptushkin, Vadim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195665/ https://www.ncbi.nlm.nih.gov/pubmed/37202442 http://dx.doi.org/10.1038/s41375-023-01891-3 |
Ejemplares similares
-
PB1866: IS ALLO-HSCT IN CR1 NECESSARY FOR AML PATIENTS WITH MRD NEGATIVITY ACHIEVED AFTER THE FIRST INDUCTION COURSE? RUSSIAN PROSPECTIVE MULTICENTER RANDOMIZED TRIAL IN AML PATIENTS UNDER THE AGE OF 60
por: Parovichnikova, Elena, et al.
Publicado: (2023) -
PB1912: BTK AND PLCG2 GENE MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH RESISTANCE TO COVALENT BTK INHIBITOR
por: Likold, Ekaterina, et al.
Publicado: (2023) -
P396: FIFTEEN YEARS OF RUSSIAN RESEARCH IN THE TREATMENT OF ADULT PATIENTS WITH ACUTE PH-NEGATIVE LYMPHOBLASTIC LEUKEMIA ACCORDING TO THE PROTOCOLS ALL-2009 AND ALL-2016.
por: Aleshina (Gavrilina), Olga, et al.
Publicado: (2023) -
PB1874: BTK GENE MUTATIONS IN RUSSIAN PATIENTS TREATED WITH IBRUTINIB: AS-PCR VERSUS NGS FOR ALLELIC LOAD ASSESSMENT
por: Likold, E., et al.
Publicado: (2022) -
P566: RESULTS OF NON-CHEMOTERAPEUTIC TREATMENT OF PATIENTS WITH DE NOVO ACUTE PROMYELOCYTIC LEUKEMIA
por: Troitskaya, Vera, et al.
Publicado: (2023)